These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 10022813)
1. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer. Millar DS; Ow KK; Paul CL; Russell PJ; Molloy PL; Clark SJ Oncogene; 1999 Feb; 18(6):1313-24. PubMed ID: 10022813 [TBL] [Abstract][Full Text] [Related]
2. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372 [TBL] [Abstract][Full Text] [Related]
3. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Song JZ; Stirzaker C; Harrison J; Melki JR; Clark SJ Oncogene; 2002 Feb; 21(7):1048-61. PubMed ID: 11850822 [TBL] [Abstract][Full Text] [Related]
4. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy. Bastian PJ; Palapattu GS; Lin X; Yegnasubramanian S; Mangold LA; Trock B; Eisenberger MA; Partin AW; Nelson WG Clin Cancer Res; 2005 Jun; 11(11):4037-43. PubMed ID: 15930338 [TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker? Bernardini S; Miano R; Iori R; Finazzi-Agrò E; Palmieri G; Ballerini S; Angeloni C; Orlandi A; Bellincampi L; Cortese C; Federici G Clin Chim Acta; 2004 Dec; 350(1-2):181-8. PubMed ID: 15530476 [TBL] [Abstract][Full Text] [Related]
6. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Brooks JD; Weinstein M; Lin X; Sun Y; Pin SS; Bova GS; Epstein JI; Isaacs WB; Nelson WG Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):531-6. PubMed ID: 9641498 [TBL] [Abstract][Full Text] [Related]
7. The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma. Chu DC; Chuang CK; Fu JB; Huang HS; Tseng CP; Sun CF J Urol; 2002 Apr; 167(4):1854-8. PubMed ID: 11912447 [TBL] [Abstract][Full Text] [Related]
8. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells. Lin X; Nelson WG Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808 [TBL] [Abstract][Full Text] [Related]
9. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Lee WH; Isaacs WB; Bova GS; Nelson WG Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):443-50. PubMed ID: 9184779 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci. Bastian PJ; Ellinger J; Wellmann A; Wernert N; Heukamp LC; Müller SC; von Ruecker A Clin Cancer Res; 2005 Jun; 11(11):4097-106. PubMed ID: 15930345 [TBL] [Abstract][Full Text] [Related]
11. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells. Singal R; van Wert J; Bashambu M Cancer Res; 2001 Jun; 61(12):4820-6. PubMed ID: 11406558 [TBL] [Abstract][Full Text] [Related]
14. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer. Nakayama M; Gonzalgo ML; Yegnasubramanian S; Lin X; De Marzo AM; Nelson WG J Cell Biochem; 2004 Feb; 91(3):540-52. PubMed ID: 14755684 [TBL] [Abstract][Full Text] [Related]
15. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858 [TBL] [Abstract][Full Text] [Related]
16. Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. Nelson CP; Kidd LC; Sauvageot J; Isaacs WB; De Marzo AM; Groopman JD; Nelson WG; Kensler TW Cancer Res; 2001 Jan; 61(1):103-9. PubMed ID: 11196146 [TBL] [Abstract][Full Text] [Related]
17. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. Wang LG; Beklemisheva A; Liu XM; Ferrari AC; Feng J; Chiao JW Mol Carcinog; 2007 Jan; 46(1):24-31. PubMed ID: 16921492 [TBL] [Abstract][Full Text] [Related]
18. Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis. Gonzalgo ML; Nakayama M; Lee SM; De Marzo AM; Nelson WG Urology; 2004 Feb; 63(2):414-8. PubMed ID: 14972513 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Stirzaker C; Song JZ; Davidson B; Clark SJ Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996 [TBL] [Abstract][Full Text] [Related]
20. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Cairns P; Esteller M; Herman JG; Schoenberg M; Jeronimo C; Sanchez-Cespedes M; Chow NH; Grasso M; Wu L; Westra WB; Sidransky D Clin Cancer Res; 2001 Sep; 7(9):2727-30. PubMed ID: 11555585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]